The immunosuppressive effects of low molecular weight chitosan on thymopentin-activated mice bearing H22 solid tumors

Int Immunopharmacol. 2021 Oct:99:108008. doi: 10.1016/j.intimp.2021.108008. Epub 2021 Jul 27.

Abstract

In the present study, the low molecular weight of chitosan (CS) was prepared and its activity on thymopentin-activated mice bearing H22 solid tumors was further researched. The purity and molecular weight of CS were determined by UV and HPGPC spectra, and its immunosuppressive effects on H22 tumor-bearing mice were evaluated through determination on immune organs, cells and cytokines. Results showed that CS contained little impurities with the average molecular weight of 1.20 × 104 Da. The in vivo antitumor experiments demonstrated that CS facilitated to destroy immune organs (thymuses and spleens), suppress immune cells (lymphocytes, macrophages and NK cells) activities and reduce immune-related cytokines (TNF-α, IFN-γ, IL-2 and IL-4) expressions of H22 tumor-bearing mice even with simultaneous TP5 stimulation. Our data suggested that CS could not be applied to improve immune response in cancer-bearing patients, but might be employed for treatments on autoimmune diseases or organ transplant patients.

Keywords: Immunosuppression; Low molecular weight chitosan; Thymopentin.

Publication types

  • Letter

MeSH terms

  • Animals
  • Blood Cell Count
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / immunology*
  • Carcinoma, Hepatocellular / pathology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Chitosan / pharmacology*
  • Cytokines / blood
  • Female
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / immunology*
  • Liver Neoplasms / pathology
  • Mice
  • Mice, Inbred BALB C
  • Molecular Weight
  • T-Lymphocytes / metabolism
  • Thymopentin

Substances

  • Cytokines
  • Chitosan
  • Thymopentin